Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70

Clinical trial NCT00027131 · TERMINATED

Trial details

NCT number: NCT00027131
Sponsor: UConn Health
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2000-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.